TRCT
MAIA icon

Tower Research Capital (TRC)’s MAIA Biotechnology MAIA Stock Holding History

Tower Research Capital (TRC)’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.62K Buy
+3,208
New +$4.26K ﹤0.01% 4367
2025
Q4 		– Sell
-4,026
Closed -$6.2K – 5417
2025
Q3 		$6.2K Buy
4,026
+2,179
+118% +$3.56K ﹤0.01% 4174
2025
Q2 		$3.33K Buy
1,847
+1,608
+673% +$2.88K ﹤0.01% 4520
2025
Q1 		$366 Sell
239
-3,046
-93% -$5.64K ﹤0.01% 4920
2024
Q4 		$6.5K Buy
3,285
+1,819
+124% +$4.36K ﹤0.01% 4164
2024
Q3 		$4.12K Sell
1,466
-3,273
-69% -$10.2K ﹤0.01% 4667
2024
Q2 		$16.2K Sell
4,739
-926
-16% -$2.92K ﹤0.01% 3876
2024
Q1 		$12.5K Buy
5,665
+2,071
+58% +$3.11K ﹤0.01% 3479
2023
Q4 		$4.21K Sell
3,594
-1,329
-27% -$2.15K ﹤0.01% 4982
2023
Q3 		$10.8K Buy
4,923
+961
+24% +$1.9K ﹤0.01% 4072
2023
Q2 		$8.72K Buy
3,962
+1,256
+46% +$3.36K ﹤0.01% 4381
2023
Q1 		$9K Buy
+2,706
New +$11.1K ﹤0.01% 4511
2022
Q4 		– Sell
-311
Closed -$1K – 6182
2022
Q3 		$1K Buy
+311
New +$1.32K ﹤0.01% 5805

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tower Research Capital (TRC)'s MAIA Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 3,208 shares worth $4.62K. The stake represents ﹤0.01% of the portfolio and ranks #4367 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in MAIA as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in MAIA in Q3 2022 and has held it in 13 quarters since. The position peaked at $16.2K in Q2 2024. 36 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Tower Research Capital (TRC) held 3,208 shares of MAIA Biotechnology worth $4.62K as of Q2 2026.
  • MAIA Biotechnology was a new Tower Research Capital (TRC) position in Q2 2026.
  • MAIA Biotechnology made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4367 holding.
  • Tower Research Capital (TRC) first reported a position in MAIA Biotechnology in Q3 2022 and has held it in 13 quarters since.
  • Tower Research Capital (TRC)'s MAIA Biotechnology position peaked at $16.2K in Q2 2024.
  • 36 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.